2023-2030年全球嗜睡剂市场
市场调查报告书
商品编码
1296863

2023-2030年全球嗜睡剂市场

Global Nootropics Market 2023-2030

出版日期: | 出版商: Orion Market Research | 英文 130 Pages | 商品交期: 2-3个工作天内

价格

在预测期内(2023-2030年),全球助脑剂市场预计将以14.1%的年复合增长率增长。对健脑剂和智能药物的需求不断增加,是推动全球助脑剂市场增长的一个关键因素。大量的学生和专业人士消费这些智能药物来提高注意力和记忆力。使用合成和天然原料的持续产品开发预计将推动产品需求。例如,2020年10月,总部设在澳大利亚的诺托品初创公司Neuratech推出了2种针对注意力和压力的大脑健康补充剂,名为Boost和Calm。Boost是一种注意力和能量的诺托品,而Calm是一种压力和睡眠诺托品。此外,由于消费者正在寻求天然营养品,对有机营养品如咖啡和含有天然成分的补充剂的需求激增,如Brahmi、北极根、姜黄、人参和松树皮。

健身房文化越来越受欢迎,因为在过去10年中,健身房的会员数量增加得更多。因此,性能营养食品,如诺托品,在千禧一代中越来越受欢迎,他们更多的参与到健身活动中。有关诺托品的研究和开发活动数量的增加预计将为市场增长提供有利可图的机会。然而,与药物开发和分销相关的高成本可能会限制市场的增长。在预测期内,与用药有关的副作用也可能限制市场的增长。

目录

第一章:报告摘要

  • 当前行业分析和增长潜力展望
  • 研究方法和工具
  • 市场细分
    • 按领域划分
    • 按地区

第二章:市场概述和洞察力

  • 报告的范围
  • 分析师的洞察力和当前的市场趋势
    • 主要发现
    • 建议
    • 总结

第三章:竞争格局

  • 主要公司分析
  • Pfizer Inc..
    • 概述
    • 财务分析
    • SWOT分析
    • 近期发展情况
  • GlaxoSmithKline plc
    • 概况
    • 财务分析
    • SWOT分析
    • 近期发展情况
  • Novartis AG
    • 进展概况
    • 财务分析
    • SWOT分析
    • 近期发展
  • 关键战略分析

第四章:市场细分

  • 按形式分類的全球诺托品市场
    • 胶囊/片剂
    • 粉剂
    • 饮料
  • 按分销渠道分類的全球诺托品市场
    • 线下
    • 线上

第五章:区域分析

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 意大利
    • 西班牙
    • 法国
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 世界其他地区

第六章:公司简介

  • AstraZeneca Plc
  • Cephalon A/S
  • GlaxoSmithKline plc
  • Johnson & Johnson Private Ltd.
  • Kimera Koffee
  • Koios Beverage Corp
  • Mental Mojo, LLC
  • Mylan N.V.
  • Novartis AG
  • Onnit Labs, Inc.
  • Opti-Nutra Ltd.
  • Pfizer Inc.
  • Reckitt Benckiser Group PLC
  • Reckitt Benckiser Group plc
  • Sanofi SA
  • Savvy Beverage
  • Teva Pharmaceutical Industries Ltd.
  • TruBrain Inc.
  • Wolfson Brands (Noocube)
  • Zhou Nutrition LLC
Product Code: OMR2027349

Title: Global Nootropics Market Size, Share & Trends Analysis Report by Form (Capsules/ Tablets, Powder, and Drinks), and by Distribution Channel (Online and Offline) Forecast Period (2023-2030).

The global nootropics market is anticipated to grow at a CAGR of 14.1% during the forecast period (2023-2030). The increasing demand for brain boosters and smart drugs is a key factor driving the growth of the global nootropics market. A large number of students and professionals consume these smart drugs to improve focus and memory. Continuous product development using both synthetic and natural raw materials is anticipated to fuel the product demand. For instance, in October 2020, Australia-based nootropic start-up Neuratech launched 2 brain health supplements for focus and stress, named Boost and Calm. Boost is a focus and energy nootropic, while Calm is a stress and sleep nootropic. Furthermore, the demand for organic nootropics such as coffee and supplements with natural ingredients such as Brahmi, arctic root, turmeric, ginseng, and pine bark witnessed a surge as consumers are seeking natural nootropics products.

Gym cultures is increasingly becoming popular as gym membership have increased with a higher late in last 10 years. Therefore, performance nutrition foods such as nootropics are gaining popularity among millennial are known to be more involved in fitness activates. Increase in the number of research and development activities regarding nootropics is expected to offer lucrative opportunities to the market growth. However, high cost associated with drug development and distribution may restrain the market growth. The side effects linked with administration of nootropics may also restrain the market growth during the forecast period.

Segmental Outlook

The global nootropics market is segmented on the form and distribution channel. Based on the form, the market is sub-segmented into capsules/tablets, powder, and drinks. On the basis of distribution channel, the market is sub-segmented into online and offline. Among the distribution channels, the offline sub-segment is expected to hold a prominent share of the global market, owing to the growing penetration of independent retail companies such as Walmart Tesco, and others. The retail giants further bolster the product visibility and attract a larger consumer base.

Drinks Sub-Segment is Anticipated to hold a Prominent Growth in the Global Nootropics Market

Among the form segment, the drinks sub-segment is expected to hold a prominent growth in the market across the globe. The primary factor supporting the segmental growth includes the rising development and introduction of nootropics or smart drugs in the form of either capsule or tablet. For instance, in January 2020, Sun Chaser, a beverage brand start-up launched pre-orders of their beverages on its official website. The beverage is a carbonated alcohol alternative which does not contain caffeine and booze. Sun Chaser leverages L-theanine and cordyceps for an alcohol alternative. Through this launch, the brand aims to tap into the broad market of functional nootropic ingredients.

Regional Outlook

The global nootropics market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America. Among these, North America is anticipated to hold a prominent share of the market across the globe, owing to the presence of key market players. The rising focus on health along with the rising awareness regarding nootropics is further driving the product demand in this region.

The overall supplements market in North America is growing exponentially, and the use of supplements to enhance the productivity of the brain has helped pave the way for nootropics. Retailers, both online and brick-and-mortar stores, are thereby creating prominent shelf lines for nootropics supplements to cater to the needs of consumers, ranging from teenagers to older adults.

Global Nootropics Market Growth, by Region 2023-2030

Source: OMR Analysis

The Asia-Pacific Region is Expected to Grow at a Significant CAGR in the Global Nootropics Market

Among all regions, the Asia-Pacific region is anticipated to grow at a considerable CAGR over the forecast period. Increasing awareness towards personal health in growing economies such as India & China is one of the key factors driving the growth of the global nootropics market. Chronic diseases such as heart disease, cancer, diabetes, stroke, and arthritis have been on the rise, in recent times. As per the International Diabetes Federation (IDF), around 250 million adults in the age range of 20-79 years were living with diabetes in the region in 2019. These numbers are further expected to rise over a certain period owing to the changing eating habits and more inclination towards unhealthy food diets. The rise in the prevalence of chronic diseases prompts the need for nootropics, which drives the regional growth of the market.

Market Players Outlook

The major companies serving the nootropics market include Pfizer Inc., GlaxoSmithKline plc, Novartis AG, Mylan N.V., and Teva Pharmaceutical Industries Ltd. Among others. The market players are considerably contributing to the market growth by the adoption of various strategies including funding for R&D, and new product development, mergers & acquisition, and distribution network expansion among others to remain competitive in the market place. For instance, in October 2022, Shine Drink, Australia's first energy nootropic drink developed with natural nootropics has launched into Woolworths stores nationwide. Additionally, in July 2021, Snack bars was hoping to raise $ 2,48,132 to progress its mission to get true functional nutrition into the hands of the mass market.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global nootropics market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Pfizer Inc..
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. GlaxoSmithKline plc
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Novartis AG
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Nootropics Market by Form
    • 4.1.1. Capsules/ Tablets
    • 4.1.2. Powder
    • 4.1.3. Drinks
  • 4.2. Global Nootropics Market by Distribution Channel
    • 4.2.1. Offline
    • 4.2.2. Online

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. AstraZeneca Plc
  • 6.2. Cephalon A/S
  • 6.3. GlaxoSmithKline plc
  • 6.4. Johnson & Johnson Private Ltd.
  • 6.5. Kimera Koffee
  • 6.6. Koios Beverage Corp
  • 6.7. Mental Mojo, LLC
  • 6.8. Mylan N.V.
  • 6.9. Novartis AG
  • 6.10. Onnit Labs, Inc.
  • 6.11. Opti-Nutra Ltd.
  • 6.12. Pfizer Inc.
  • 6.13. Reckitt Benckiser Group PLC
  • 6.14. Reckitt Benckiser Group plc
  • 6.15. Sanofi SA
  • 6.16. Savvy Beverage
  • 6.17. Teva Pharmaceutical Industries Ltd.
  • 6.18. TruBrain Inc.
  • 6.19. Wolfson Brands (Noocube)
  • 6.20. Zhou Nutrition LLC

LIST OF TABLES

  • 1. GLOBAL NOOTROPICS MARKET RESEARCH AND ANALYSIS BY FORM, 2022-2030 ($ MILLION)
  • 2. GLOBAL NOOTROPICS CAPSULES/ TABLETS MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
  • 3. GLOBAL NOOTROPICS POWDER MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL NOOTROPICS DRINKS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 5. GLOBAL NOOTROPICS MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)
  • 6. GLOBAL NOOTROPICS IN OFFLINE MARKET RESEARCH AND ANALYSIS, 2022-2030 ($ MILLION)
  • 7. GLOBAL NOOTROPICS IN ONLINE MARKET RESEARCH AND ANALYSIS, 2022-2030 ($ MILLION)
  • 8. GLOBAL NOOTROPICS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 9. NORTH AMERICAN NOOTROPICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 10. NORTH AMERICAN NOOTROPICS MARKET RESEARCH AND ANALYSIS BY FORM, 2022-2030 ($ MILLION)
  • 11. NORTH AMERICAN NOOTROPICS MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)
  • 12. EUROPEAN NOOTROPICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 13. EUROPEAN NOOTROPICS MARKET RESEARCH AND ANALYSIS BY FORM, 2022-2030 ($ MILLION)
  • 14. EUROPEAN NOOTROPICS MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)
  • 15. ASIA- PACIFIC NOOTROPICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 16. ASIA- PACIFIC NOOTROPICS MARKET RESEARCH AND ANALYSIS BY FORM, 2022-2030 ($ MILLION)
  • 17. ASIA- PACIFIC NOOTROPICS MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)
  • 18. REST OF THE WORLD NOOTROPICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 19. REST OF THE WORLD NOOTROPICS MARKET RESEARCH AND ANALYSIS BY FORM, 2022-2030 ($ MILLION)
  • 20. REST OF THE WORLD NOOTROPICS MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL NOOTROPICS MARKET SHARE BY FORM, 2022 VS 2030 (%)
  • 2. GLOBAL NOOTROPICS CAPSULES/TABLETS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL NOOTROPICS POWDER MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL NOOTROPICS DRINKS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 5. GLOBAL NOOTROPICS MARKET SHARE ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)
  • 6. GLOBAL NOOTROPICS IN OFFLINE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 7. GLOBAL NOOTROPICS IN ONLINE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 8. GLOBAL NOOTROPICS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 9. US NOOTROPICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 10. CANADA NOOTROPICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 11. UK NOOTROPICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 12. FRANCE NOOTROPICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 13. GERMANY NOOTROPICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 14. ITALY NOOTROPICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 15. SPAIN NOOTROPICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 16. REST OF EUROPE NOOTROPICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 17. INDIA NOOTROPICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. CHINA NOOTROPICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. JAPAN NOOTROPICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. SOUTH KOREA NOOTROPICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. REST OF ASIA-PACIFIC NOOTROPICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. REST OF THE WORLD NOOTROPICS MARKET SIZE, 2022-2030 ($ MILLION)